Cargando…
Dynamical Basis for Drug Resistance of HIV-1 Protease
BACKGROUND: Protease inhibitors designed to bind to protease have become major anti-AIDS drugs. Unfortunately, the emergence of viral mutations severely limits the long-term efficiency of the inhibitors. The resistance mechanism of these diversely located mutations remains unclear. RESULTS: Here I u...
Autor principal: | Mao, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149572/ https://www.ncbi.nlm.nih.gov/pubmed/21740562 http://dx.doi.org/10.1186/1472-6807-11-31 |
Ejemplares similares
-
Molecular Basis for Drug Resistance in HIV-1 Protease
por: Ali, Akbar, et al.
Publicado: (2010) -
Analysis of drug resistance in HIV protease
por: Pawar, Shrikant D., et al.
Publicado: (2018) -
Evolution of drug resistance in HIV protease
por: Shah, Dhara, et al.
Publicado: (2020) -
Drug Resistance Mutations Alter Dynamics of Inhibitor-Bound HIV-1 Protease
por: Cai, Yufeng, et al.
Publicado: (2014) -
The structural, dynamic, and thermodynamic basis of darunavir resistance of a heavily mutated HIV-1 protease using molecular dynamics simulation
por: Shabanpour, Yaser, et al.
Publicado: (2022)